Projected Cost-Effectiveness of Pneumococcal Conjugate Vaccination of Healthy Infants and Young Children
This study, published in the Journal of American Medical Association, evaluates the projected health and economic impact of pneumococcal conjugate vaccination of healthy US infants and young children through a cost-effectiveness analysis based on data from the Northern California Kaiser Permanente randomized trial and other published and unpublished sources. ABSTRACT ONLY. (Learn how users in developing countries can gain free access to journal articles.)
Author(s): Lieu TA, Ray GT, Black SB, et al.
Visit web page (English)
(Located at www.ncbi.nlm.nih.gov)
Citation: Lieu TA, Ray GT, Black SB, et al. Projected Cost-effectiveness of Pneumococcal Conjugate Vaccination of Healthy Infants and Young Children. Journal of the American Medical Association. 2000;283(11):1460-1468.